NCT07078409

Clinician Nudge to Referral of Adnexal Masses to Gynecologic Oncology

Enrolling by Invitation
NAAges 18+InterventionalDiagnostic
Abramson Cancer Center at Penn Medicine
~240 participants
Updated 2025-07-22 on ClinicalTrials.gov
What's tested:Nudge

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Referral Rate
Measured over Up to one year
Ovarian Cancer
1 sites across 1 states
Pennsylvania1

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Eligible clinicians include physicians, physician assistants, and nurse practitioners with eligible patient encounters at sites included in the trial during the study.
Eligible patient encounters are defined as an emergency room visit, inpatient hospitalization, or outpatient visit during the study period where the patient had associated imaging with suspected ovarian cancer (O-RADS 4 or 5 lesion), identified with the EHR-based tool described above.

Exclusion

Known diagnosis of ovarian cancer.
Imaging ordered by gynecologic oncologist.
  • Referral RateUp to one year

    Binary indicator of whether the patient was referred to gynecologic oncology within 14 days of abnormal imaging results.